Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Mesa Laboratories (MLAB) just unveiled an update.
Mesa Laboratories, Inc. recently revised its senior secured credit agreement with a banking syndicate led by JPMorgan Chase, enhancing its financial flexibility. The modifications include a new $75 million term loan, an extended credit facility maturity to April 2029, and adjustments to financial covenants. The company also retains a $125 million revolving credit facility to support its working capital and corporate needs, including potential acquisitions. Additionally, Mesa has negotiated the repurchase of $75 million of its 1.375% Convertible Notes due in 2025, reducing its outstanding debt and streamlining its capital structure.
For a thorough assessment of MLAB stock, go to TipRanks’ Stock Analysis page.